PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 143 filers reported holding PLIANT THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.42 and the average weighting 1.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,419,209 | +7.0% | 81,846 | +11.8% | 0.00% | – |
| Q2 2023 | $1,326,330 | +134.7% | 73,197 | +244.8% | 0.00% | – |
| Q1 2023 | $565,000 | +194727.6% | 21,227 | +41.9% | 0.00% | – |
| Q4 2022 | $290 | -100.0% | 14,959 | -59.5% | 0.00% | – |
| Q3 2022 | $772,000 | +5838.5% | 36,971 | +2231.1% | 0.00% | – |
| Q2 2022 | $13,000 | -88.2% | 1,586 | -89.9% | 0.00% | – |
| Q1 2022 | $110,000 | -84.9% | 15,755 | -70.7% | 0.00% | – |
| Q4 2021 | $727,000 | +159.6% | 53,836 | +224.9% | 0.00% | – |
| Q3 2021 | $280,000 | -26.7% | 16,568 | +26.3% | 0.00% | – |
| Q2 2021 | $382,000 | -67.3% | 13,120 | -55.8% | 0.00% | – |
| Q1 2021 | $1,167,000 | +1000.9% | 29,690 | +534.9% | 0.00% | – |
| Q4 2020 | $106,000 | +15.2% | 4,676 | +20.4% | 0.00% | – |
| Q3 2020 | $92,000 | – | 3,883 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 1,839,160 | $35,550,963 | 27.86% |
| TRV GP IV, LLC | 2,132,867 | $41,228,319 | 17.53% |
| CHI Advisors LLC | 3,169,892 | $61,274,012 | 16.32% |
| GREAT POINT PARTNERS LLC | 1,322,870 | $25,571,077 | 5.01% |
| VR Adviser, LLC | 1,080,000 | $20,876,400 | 3.52% |
| Redmile Group, LLC | 3,878,599 | $74,973,319 | 3.07% |
| Casdin Capital, LLC | 1,675,000 | $32,377,750 | 2.51% |
| Fernwood Investment Management, LLC | 304,573 | $5,887,396 | 2.44% |
| Cheyne Capital Management (UK) LLP | 66,144 | $1,278,564 | 2.23% |
| First Light Asset Management, LLC | 1,057,881 | $20,448,840 | 1.90% |